肿瘤防治研究2025，Vol.52Issue(11)：879-912,34.DOI:10.3971/j.issn.1000-8578.2025.25.0771
中国肿瘤共病防治专家共识(2025版)
Chinese Expert Consensus on Oncology Multimorbidity Management(2025 Edition)
中国临床肿瘤学会(CSCO)肿瘤支持与康复治疗专家委员会 1潘宏铭 2王杰军 3罗素霞 4秦叔逵5
作者信息
- 2. 香港大学深圳医院肿瘤科
- 3. 蚌埠医科大学第一附属医院
- 4. 河南省肿瘤医院
- 5. 中国药科大学附属天印山医院
- 折叠
摘要
Abstract
Against the backdrop of accelerated population aging,the prevalence of comorbidities in patients with malignant tumors has risen by 0.54%annually,presenting a significant challenge to clinical oncology.Currently,the awareness of oncology multimorbidities varies significantly among specialists at different levels of healthcare institutions nationwide,and a comprehensive management workflow for patients with cancer and multimorbidities is lacking.Therefore,the Chinese Society of Clinical Oncology Committee of Experts on Cancer Supportive and Rehabilitation Therapy convened a multidisciplinary panel of experts to develop the Chinese Expert Consensus on Oncology Multimorbidity Management(2025 Edition).Aimed at frontline clinicians involved in the diagnosis and treatment of malignant tumors,the consensus addresses 29 core issues in multimorbidities management and guides the standardized,comprehensive management of oncology multimorbidities.关键词
肿瘤共病/评估/多学科协作/专家共识Key words
Oncology multimorbidity/Assessment/MDT/Expert Consensus分类
临床医学引用本文复制引用
中国临床肿瘤学会(CSCO)肿瘤支持与康复治疗专家委员会,潘宏铭,王杰军,罗素霞,秦叔逵..中国肿瘤共病防治专家共识(2025版)[J].肿瘤防治研究,2025,52(11):879-912,34.
